Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-tumoral heterogeneity, the cellular differentiation state, and the interaction between subclonal evolution and transcriptional heterogeneity, on the other hand, are poorly understood. The authors performed single-cell RNA sequencing on 14 untreated PCa patients in this study. They developed a comprehensive cell atlas of PCa patients and mapped developmental states onto tumor subclonal evolution. They find distinct subclones in PCa patients and then divide tumor cells into four transcriptional subtypes: EMT-like (subtype 0), luminal A-like (subtype 1), luminal B/C-like (subtype 2), and basal-like (subtype 3). These subtypes are organized hierarchically into stem cell-like and differentiated states. Surprisingly, multiple subclones within a single primary tumor have distinct preferential subtype combinations. Furthermore, subclones exhibit varying levels of communication with other cell types within the tumor ecosystem, which may modulate the distinct transcriptional subtypes of the subclones. Notably, they discovered that tumor cell transcriptional heterogeneity and cellular ecosystem diversity correlate with features of a poor prognosis by integrating TCGA data. Their research examines subclonal and transcriptional heterogeneity and its implications for patient prognosis.
What Are the Main Processes of DNA Microarray Technology?March 8, 2023The principle of DNA microarray technology is to integrate gene probes with known sequences onto a solid surface. A large number of labeled nucleic acid sequences from the tested biological cells or t...view
What Is the Application of Bacterial Genome Sequencing?November 10, 2023Bacterial genome sequencing has become an essential part of modern biology and medicine. This advanced technology allows scientists to decipher the complete set of genes in a bacterial cell, revealing...view
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view
Breaking Barriers: Innovations in Gynecologic Cancer TreatmentJune 26, 2023Gynecologic cancers, which include ovarian, uterine, cervical, vaginal, and vulvar cancers, affect thousands of women worldwide. The diagnosis of gynecologic cancer can be devastating, but thanks to o...view
Microfluidic Chips: What Do You Know?April 4, 2023Microfluidic chip technology integrates the basic operational units of sample preparation, reaction, separation, detection and more involved in biological, chemical and medical analysis processes onto...view
What is a Microfluidic Chip?September 27, 20221. Basic definition of microfluidic chipMicrofluidic chip, also known as Lab-on-chip, is a science and technology characterized by the manipulation of fluids in the micron-scale space.At present, the ...view